
French interior minister wins contest to lead conservative party
PARIS (Reuters) -French Interior Minister Bruno Retailleau was voted the new leader of the centre-right Republicans (LR) party on Sunday, bolstering his chances ahead of a 2027 presidential election in which many believe he will run.
With just over 74% of the vote in an internal LR election, Retailleau comfortably beat Laurent Wauquiez, who leads the party in France's lower house of parliament.
Wauquiez caused outrage during the campaign with a proposal that migrants awaiting deportation should be shipped off to the remote French-controlled islands of Saint Pierre and Miquelon off Canada's coast.
Since becoming interior minister last year, Retailleau has sought to crack down on immigration and drug crime, but has struggled to show strong results on either front.
The rise in popularity of Marine Le Pen's National Rally (RN) has contributed to a right-ward shift in French politics, and Retailleau's high-profile job and conservative views could make him a viable candidate for the 2027 election.
"Mr. Retailleau's rhetoric is a clear-cut theft of the National Rally," said RN spokesman Laurent Jacobelli. "If we look at his actions, however, there is a gap between rhetoric and reality."
Once a cornerstone of French politics, created by former President Nicolas Sarkozy as a continuation of fellow ex-president Jacques Chirac's party, LR is now a faded force with just 48 seats in parliament, far behind the RN's 123.
(Reporting by Gabriel StargardterAdditional reporting by Gus TrompizEditing by Peter Graff)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Star
5 hours ago
- The Star
AstraZeneca vows to spend US$50bil on US manufacturing boost
LONDON: AstraZeneca Plc plans to invest US$50bil in the United States before 2030, becoming the latest European pharma company to ratchet up spending in the country ahead of potential tariffs on imported medicines. The investment will go towards manufacturing as well as research and development, Astra said in a statement. It includes US$4bil for a new facility in Virginia that will make drugs for chronic diseases, Kevin Hassett, director of the US National Economic Council, said on Monday at an event in Washington. 'With the completion of this investment, substantially all of AstraZeneca's pharmaceuticals sold in the United States will be produced in the United States,' he said. Astra will also manufacture its experimental weight-loss pill at the facility in Virginia, following an earlier pledge from rival Eli Lilly & Co, which is also planning to make its obesity pill in the United States. The announcement comes as European drug companies rush to highlight their US investments with the aim of mitigating the impact of tariffs from President Donald Trump. Astra already announced plans in November, a week after Trump's election, to invest US$3.5bil in the United States by the end of 2026, noting at the time that it employs nearly 18,000 people in the country. The company said the latest investment announcement is in addition to that earlier amount. Since Trump's election, European competitors have touted ever-larger spending plans. Switzerland's Novartis AG in April announced plans for US$23bil in US-based infrastructure spending, while cross-town rival Roche Holding AG said it would invest US$50bil. In May, French drugmaker Sanofi announced intent to invest at least US$20bil in the United States by 2030. Pascal Soriot, who's been chief executive officer of Astra since 2012, had urged tariff restraint from US policymakers. This spring, he recommended that US officials exempt medicines from tariffs, arguing that tax incentives are a better way to attract investment in drug development and manufacturing. On Monday, Soriot said he understands the need for countries to have medicines manufactured domestically. 'It's a question of national security,' he said. 'This is a vision that the president and his administration have put out there, and a vision that we totally understand, totally support, and the tariffs are accelerating a movement that we would have made in any case.' Trump has proposed various timelines for tariffs on pharmaceuticals, most recently floating duties that would start as soon as Aug 1. The president said he expects to give companies a year to bring manufacturing to the United States before imposing tariffs as high as 200%. Meanwhile, Soriot has raised concerns in the United Kingdom about his company's commitment to its home country. He has long complained about the United Kingdom's regulatory environment, which he says is a threat to hold the nation back from staying competitive with the United States and China. In January, Astra abandoned plans for a £450mil vaccine manufacturing plant in Liverpool. The company operates 17 manufacturing sites in 12 US states. Earlier this month, British paper The Times reported that Soriot is considering moving the company's stock listing to the United States. — Bloomberg


The Sun
16 hours ago
- The Sun
Amnesty demands war crimes probe into Israel's Tehran prison strike
PARIS: Amnesty International has urged a war crimes investigation into Israel's airstrike on Tehran's Evin prison during last month's conflict. The attack, confirmed by Israel, killed 79 people, per Iranian authorities, and damaged part of the facility housing political detainees. The rights group labeled the strike 'deliberate' and a breach of international humanitarian law, demanding accountability. 'The Israeli military carried out multiple air strikes on Evin prison, killing and injuring scores of civilians and causing extensive damage,' Amnesty stated, citing verified footage and witness accounts. Evin prison, known for holding political prisoners and foreign nationals, was not a 'legal military objective,' Amnesty argued. The June 13 bombardment targeted Iranian nuclear capabilities, but the June 23 strike hit staff, inmates, and nearby residents. Among detainees were French nationals Cecile Kohler and Jacques Paris, arrested for alleged espionage. Unharmed, they were later relocated. Western governments view them as hostages used for diplomatic leverage. – AFP


New Straits Times
19 hours ago
- New Straits Times
France's top diplomat calls for foreign press access to Gaza
PARIS: French Foreign Minister Jean-Noel Barrot on Tuesday called on Israel to allow foreign press into the besieged Palestinian territory of Gaza, as warnings of famine mount after 21 months of war. He spoke after the AFP news agency warned that the lives of Palestinian freelance journalists it was working with in Gaza were in danger and urged Israel to allow them and their families to leave the occupied coastal territory. "I ask that the free and independent press be allowed to access Gaza to show what is happening there and to bear witness," Barrot told France Inter radio in an interview from eastern Ukraine. Asked if France would help AFP stringers leave Gaza, Barrot said France was "addressing the issue" and hoped to be able to evacuate freelancers working with French journalists "in the coming weeks." On Monday, an association of journalists at AFP called the Societe des Journalistes (Society of Journalists) sounded the alarm, urging "immediate intervention" to help reporters working with the agency in Gaza. The SDJ cited the example of one such freelancer, a 30-year-old living with his family in Gaza City, who reported on Sunday that his older brother "fell because of hunger." "We have lost journalists in conflicts, we have had injuries and prisoners in our ranks, but none of us can remember seeing a colleague die of starvation," it said. AFP management responded in a statement posted on X and Instagram which said that it shared the anguish about the "dire situation" of colleagues in Gaza. "Since October 7, Israel has prohibited access to the Gaza Strip for all international journalists. "In this context, the work of our Palestinian freelancers is crucial to inform the world," it said. "But their lives are in danger, which is why we urge the Israeli authorities to allow their immediate evacuation along with their families." AFP evacuated its eight staff members and their families from Gaza between January and April 2024. Barrot called for an "immediate ceasefire" after Israel on Monday expanded military operations to the central city of Deir el-Balah. "There is no longer any justification for the Israeli army's military operations in Gaza," he said. "This is an offensive that will exacerbate an already catastrophic situation and cause new forced displacements of populations, which we condemn in the strongest terms."